The FLUENT study design: investigating immune cell subset and neurofilament changes in patients with relapsing multiple sclerosis treated with fingolimod

Background Fingolimod is a sphingosine 1-phosphate receptor modulator for the treatment of patients with relapsing forms of multiple sclerosis (RMS). Fingolimod sequesters lymphocytes within lymphoid tissue thereby reducing the counts of circulating lymphocytes. However, fingolimod’s effects on the...

Descripción completa

Detalles Bibliográficos

Autores principales:	Jeffrey A Cohen, Amit Bar-Or, Bruce A C Cree, Yang Mao-Draayer, May H Han, Barry Singer, Ann Jannu, Scott Kolodny, Xiangyi Meng, Ryan C Winger
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	SAGE Publishing 2018-12-01
Colección:	Multiple Sclerosis Journal - Experimental, Translational and Clinical
Acceso en línea:	https://doi.org/10.1177/2055217318819245
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!